mTOR Kinase Inhibitor CC-223

An orally available inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor CC-223 inhibits the activity of mTOR, which may result in the induction of tumor cell apoptosis and a decrease in tumor cell proliferation. mTOR, a serine/threonine kinase that is upregulated in a variety of tumors, plays an important role downstream in the PI3K/AKT/mTOR signaling pathway, which is frequently dysregulated in human cancers. (NCI Thesaurus)

YOU MAY ALSO LIKE

mTOR Kinase Inhibitor AZD8055

An inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor AZD8055 inhibits the serine/threonine kinase activity…

mTOR Kinase Inhibitor AZD2014

An orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity. mTOR kinase inhibitor AZD2014 inhibits the activity…

mTOR inhibitor

A substance that blocks a protein called mTOR, which helps control cell division. Blocking mTOR’s action may keep cancer cells from growing…

MTOR Gene

This gene plays a role in apoptosis, cell growth, differentiation and proliferation.

mTOR

A protein that helps control several cell functions, including cell division and survival, and binds to rapamycin and other drugs. mTOR may…

MTNR1B wt Allele

Human MTNR1B wild-type allele is located within 11q21-q22 and is approximately 13 kb in length. This allele, which encodes melatonin receptor type…